Review of Hepatitis C Treatment Subscription Models (language only)

Item 401 #3h

Language

Page 397, after line 22, insert:

"The Department shall assess the costs, benefits, and feasibility of adopting a "subscription model" for the purchase of hepatitis C antiviral medication and necessary ancillary services (i) for a pre-determined period of time and (ii) at an annual fixed rate to be administered to state-responsible inmates held in state correctional facilities. The assessment shall include an evaluation of the terms and conditions of models adopted for correctional systems operated by other state and local governments, and the feasibility of implementing these in Virginia. The scope of this assessment shall not preclude the collection of appropriate information from pharmaceutical manufacturers, if such information is deemed necessary by the Department to complete the assessment. The Department shall report the findings of its assessment, and any relevant recommendations, to the Secretary of Public Safety and Homeland Security and the Chairs of the House Appropriations and Senate Finance and Appropriations Committees no later than November 30, 2020."